- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Lupin Limited — Updates, 18-04-2026: General Updates
18-04-2026 | 11:57 am
18-04-2026 | 11:57 am
Lupin's Somerset, New Jersey facility received a Form-483 with three observations from the US FDA. The company plans to address these observations, affirming its commitment to CGMP standards. This indicates a minor operational hurdle.
No comments yet. Be the first to comment!